Table 1.
Gene | WT(CK) | anac017-1(−Al) | anac017-2(−Al) | WT(+Al) | anac017-1(+Al) | anac017-2(+Al) |
---|---|---|---|---|---|---|
STOP1 | 1.03 ± 0.28c | 1.21 ± 0.08c | 1.23 ± 0.37c | 1.75 ± 0.15b | 2.31 ± 0.02a | 1.82 ± 0.30b |
WRKY46 | 1.02 ± 0.22d | 2.68 ± 0.1b | 2.26 ± 0.14b | 1.48 ± 0.05c | 4.03 ± 0.37a | 3.49 ± 0.23a |
WRKY47 | 1.01 ± 0.12d | 1.81 ± 0.1b | 1.46 ± 0.03c | 1.35 ± 0.04c | 3.39 ± 0.4a | 3.01 ± 0.22a |
HB7 | 1 ± 0.11d | 1.63 ± 0.15c | 1.43 ± 0.09 c | 16.96 ± 0.56 b | 21.51 ± 1.85a | 19.18 ± 1.3a |
HB12 | 1.01 ± 0.15c | 1.45 ± 0.13 b | 1.42 ± 0.18 b | 3.15 ± 0.15a | 3.33 ± 0.19a | 3.49 ± 0.19a |
ALMT1 | 1.00 ± 0.09b | 0.93 ± 0.23b | 1.03 ± 0.16b | 20.08 ± 4.52a | 18.77 ± 4.52a | 16.90 ± 1.29a |
MATE | 1.01 ± 0.17c | 2.06 ± 0.08b | 2.23 ± 0.01b | 76.7 ± 2.22a | 80.33 ± 9.47a | 67.49 ± 7.15a |
RAE1 | 1 ± 0.05c | 1.72 ± 0.42b | 1.69 ± 0.18b | 7.09 ± 0.82a | 7.94 ± 1.52a | 7.86 ± 1.37a |
ALS1 | 1 ± 0.09b | 0.54 ± 0.08c | 0.63 ± 0.05c | 1.24 ± 0.18a | 1.17 ± 0.07a | 1.16 ± 0.15a |
ALS3 | 1.01 ± 0.09c | 1.38 ± 0.14b | 1.45 ± 0.06 b | 9.36 ± 1.33a | 8.81 ± 1.79a | 9.35 ± 0.67a |
STAR1 | 1 ± 0.06b | 1.79 ± 0.12a | 1.65 ± 0.27a | 0.5 ± 0.02c | 0.98 ± 0.09b | 1.03 ± 0.06b |
XTH15 | 1.00 ± 0.11a | 0.93 ± 0.36a | 0.86 ± 0.04a | 0.96 ± 0.06a | 0.82 ± 0.07a | 0.78 ± 0.02b |
XTH17 | 1.00 ± 0.08c | 1.67 ± 0.11a | 1.36 ± 0.18b | 0.72 ± 0.06d | 0.71 ± 0.02d | 0.68 ± 0.01d |
XTH31 | 1.00 ± 0.03a | 0.69 ± 0.00b | 0.41 ± 0.01c | 0.43 ± 0.04c | 0.22 ± 0.02d | 0.24 ± 0.02d |
TBL27 | 1.00 ± 0.07c | 1.00 ± 0.13c | 1.06 ± 0.14c | 1.62 ± 0.03b | 1.77 ± 0.05a | 1.70 ± 0.01a |
Four-week-old WT and anac017 mutants were treated with or without Al for 24 h. RNA was prepared from root tissues. TUBULIN was used as an internal control. Data are means ± sd (n = 4). Different letters indicate significant differences at P < 0.05.